UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 7.651

Sortiert nach

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy

Journal of enzyme inhibition and medicinal chemistry, 2020-01, Vol.35 (1), p.993-1002

2020

Link zum Volltext

Verfügbarkeit prüfen

1.2 The Pharmacotherapy of Conduct Disorder and Related Conditions

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S84-S84

Findling, Robert L., MD, MBA

2016

Link zum Volltext

Verfügbarkeit prüfen

1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model

Neuropharmacology, 2006-02, Vol.50 (2), p.133-142

2006

Link zum Volltext

Verfügbarkeit prüfen

1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats

Journal of ethnopharmacology, 2015-08, Vol.172, p.80-84

2015

Link zum Volltext

Verfügbarkeit prüfen

A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation

The journal of clinical psychiatry, 2011-12, Vol.72 (12), p.1602

2011

Link zum Volltext

Verfügbarkeit prüfen

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

International clinical psychopharmacology, 2008-09, Vol.23 (5), p.254

2008

Link zum Volltext

Verfügbarkeit prüfen

14C-NaVP and 14C-PEV repeated dose study in rat pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester

European journal of drug metabolism and pharmacokinetics, 1998-04, Vol.23 (2), p.223-229

1998

Link zum Volltext

Verfügbarkeit prüfen

First-dose and steady-state pharmacokinetics of valproic acid in children with seizures

Clinical pharmacokinetics, 1983-01, Vol.8 (5), p.447-455

1983

Link zum Volltext

Verfügbarkeit prüfen

First seizure in adults: to treat or not to treat

Clinical neurology and neurosurgery, 1992, Vol.94, p.61-63

Chandra, Benjamin

1992

Link zum Volltext

Verfügbarkeit prüfen

2-hexyl-4-pentynoic acid, a potential therapeutic for breast carcinoma by influencing RPA2 hyperphosphorylation-mediated DNA repair

DNA repair, 2020-11, Vol.95, p.102940-102940, Article 102940

2020

Link zum Volltext

Verfügbarkeit prüfen

2-Phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice

European journal of pharmacology, 2006-02, Vol.531 (1), p.66-73

2006

Link zum Volltext

Verfügbarkeit prüfen

2-propyl-1-aminopentane, its deamination by monoamine oxidase and semicarbazide-sensitive amine oxidase, conversion to valproic acid and behavioral effects

Neuropharmacology, 1991-05, Vol.30 (5), p.507-515

1991

Link zum Volltext

Verfügbarkeit prüfen

A 20-Month, Double-Blind, Maintenance Trial of Lithium Versus Divalproex in Rapid-Cycling Bipolar Disorder

The American journal of psychiatry, 2005-11, Vol.162 (11), p.2152-2161

2005

Link zum Volltext

Verfügbarkeit prüfen

2D and 3D QSAR analysis of some valproic acid metabolites and analogues as anticonvulsant agents

Pharmaceutical research, 2000-06, Vol.17 (6), p.727-732

2000

Link zum Volltext

Verfügbarkeit prüfen

3',4'-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells

Stem cell research & therapy, 2013-05, Vol.4 (3), p.60-60, Article 60

2013

Link zum Volltext

Verfügbarkeit prüfen

3′–5′ cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone

Life sciences (1973), 1987-08, Vol.41 (5), p.605-610

1987

Link zum Volltext

Verfügbarkeit prüfen

3-Hydroxymethylphenytoin Valproic Acid Ester, a New Prodrug Combining Two Anticonvulsant Drugs

Archiv der Pharmazie (Weinheim), 1996-12, Vol.329 (12), p.554-555

Scriba, Gerhard K. E.

1996

Link zum Volltext

Verfügbarkeit prüfen

31P Magnetic Resonance Spectroscopy of Endothelial Cells Grown in Three-Dimensional Matrigel Construct as an Enabling Platform Technology: I. The Effect of Glial Cells and Valproic Acid on Phosphometabolite Levels

Endothelium (New York, N.Y.), 2008-09, Vol.15 (5-6), p.288-298

2008

Link zum Volltext

Verfügbarkeit prüfen

4-Hydroxybenzaldehyde from Gastrodia elata B1. is active in the antioxidation and GABAergic neuromodulation of the rat brain

Journal of ethnopharmacology, 2000-11, Vol.73 (1), p.329-333

2000

Link zum Volltext

Verfügbarkeit prüfen

4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques

Atherosclerosis, 2017-11, Vol.266, p.103-112

2017

Link zum Volltext

Verfügbarkeit prüfen

5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats

Neuropharmacology, 2020-05, Vol.168, p.107975-107975, Article 107975

2020

Link zum Volltext

Verfügbarkeit prüfen

5-Azacytidine upregulates melatonin MT 1 receptor expression in rat C6 glioma cells: oncostatic implications

Molecular biology reports, 2020-06, Vol.47 (6), p.4867

2020

Link zum Volltext

Verfügbarkeit prüfen

5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model

The international journal of neuropsychopharmacology, 2013-10, Vol.16 (9), p.2027-2039

2013

Link zum Volltext

Verfügbarkeit prüfen

5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure

Neurobiology of learning and memory, 2021-09, Vol.183, p.107462-107462, Article 107462

2021

Link zum Volltext

Verfügbarkeit prüfen

A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center

Pharmaceuticals (Basel, Switzerland), 2023-06, Vol.16 (7), p.945

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 7.651

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Clinical Psychopharmacology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(7.006)
Mit Volltextzugriff
(5.912)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(6.732)
Life Sciences & Biomedicine
(6.538)
Humans
(4.606)
Valproic Acid - Pharmacology
(3.726)
Male
(3.517)
Animals
(3.353)
Biological And Medical Sciences
(3.260)
Medical Sciences
(3.143)
Pharmacology. Drug Treatments
(2.839)
Valproic Acid
(2.807)
Pharmacology & Pharmacy
(2.785)
Female
(2.767)
Neurosciences & Neurology
(2.296)
Valproic Acid - Therapeutic Use
(2.016)
Neuropharmacology
(1.812)
Rats
(1.625)
Adult
(1.580)
Clinical Neurology
(1.360)
Neurosciences
(1.326)
Anticonvulsants. Antiepileptics. Antiparkinson Agents
(1.263)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Epilepsia
(387)
Therapeutic Drug Monitoring
(146)
Epilepsy Research
(134)
The Journal Of Clinical Psychiatry
(110)
Plos One
(109)
European Journal Of Pharmacology
(106)
Neurology
(103)
Epilepsia : Journal Of The International League Against Epilepsy
(90)
Neuropharmacology
(90)
Brain Research
(79)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(18)

Menü

Weitere Dienste

Einstellungen

1,2,4-Triazole-based anticonvulsant agents with additional ROS scavenging activity are effective in a model of pharmacoresistant epilepsy

1.2 The Pharmacotherapy of Conduct Disorder and Related Conditions

1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model

1-Triacontanol cerotate; isolated from Marsilea quadrifolia Linn. ameliorates reactive oxidative damage in the frontal cortex and hippocampus of chronic epileptic rats

A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: influence of valproic acid augmentation

A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode

14C-NaVP and 14C-PEV repeated dose study in rat pharmacokinetic study in rats after repeated oral administrations of 14C-valproic acid sodium salt and 14C-valproic acid pivaloyl oxymethyl ester

First-dose and steady-state pharmacokinetics of valproic acid in children with seizures

First seizure in adults: to treat or not to treat

2-hexyl-4-pentynoic acid, a potential therapeutic for breast carcinoma by influencing RPA2 hyperphosphorylation-mediated DNA repair

2-Phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice

2-propyl-1-aminopentane, its deamination by monoamine oxidase and semicarbazide-sensitive amine oxidase, conversion to valproic acid and behavioral effects

A 20-Month, Double-Blind, Maintenance Trial of Lithium Versus Divalproex in Rapid-Cycling Bipolar Disorder

2D and 3D QSAR analysis of some valproic acid metabolites and analogues as anticonvulsant agents

3',4'-Dimethoxyflavone and valproic acid promotes the proliferation of human hematopoietic stem cells

3′–5′ cyclic-guanosine monophosphate increase in rat brain hippocampus after gamma-hydroxybutyrate administration. Prevention by valproate and naloxone

3-Hydroxymethylphenytoin Valproic Acid Ester, a New Prodrug Combining Two Anticonvulsant Drugs

31P Magnetic Resonance Spectroscopy of Endothelial Cells Grown in Three-Dimensional Matrigel Construct as an Enabling Platform Technology: I. The Effect of Glial Cells and Valproic Acid on Phosphometabolite Levels

4-Hydroxybenzaldehyde from Gastrodia elata B1. is active in the antioxidation and GABAergic neuromodulation of the rat brain

4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques

5-aminolevulinic acid inhibits oxidative stress and ameliorates autistic-like behaviors in prenatal valproic acid-exposed rats

5-Azacytidine upregulates melatonin MT 1 receptor expression in rat C6 glioma cells: oncostatic implications

5-HT1A-receptor agonist modified amygdala activity and amygdala-associated social behavior in a valproate-induced rat autism model

5-HT7 receptor activation rescues impaired synaptic plasticity in an autistic-like rat model induced by prenatal VPA exposure

A 5-Year Study of Antiseizure Medications (ASMs) Monitoring in Patients with Neuropsychiatric Disorders in an Italian Clinical Center

Aktive Filter

Suchergebnisse filtern